K213486

Substantially Equivalent

GLP systems Track

Applicant: Abbott Laboratories
Product code: JGS
Advisory panel: Clinical Chemistry
Date received: 2021-10-29
Decision date: 2022-03-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Adverse events under product code JGS

product code JGS

Malfunction: 535
Total: 535

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.